Cargando…
Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1
The co-inhibitory immune checkpoint interaction between programmed cell death-protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) serves to regulate T-cell activation, promoting self-tolerance. Over-expression of PD-L1 is a mechanism through which tumour cells can evade detection by the immu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510113/ https://www.ncbi.nlm.nih.gov/pubmed/35675028 http://dx.doi.org/10.1007/s12104-022-10092-5 |
_version_ | 1784797381270700032 |
---|---|
author | Walker, Kayleigh Waters, Lorna C. Kelly, Geoff Muskett, Frederick W. Carr, Mark D. |
author_facet | Walker, Kayleigh Waters, Lorna C. Kelly, Geoff Muskett, Frederick W. Carr, Mark D. |
author_sort | Walker, Kayleigh |
collection | PubMed |
description | The co-inhibitory immune checkpoint interaction between programmed cell death-protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) serves to regulate T-cell activation, promoting self-tolerance. Over-expression of PD-L1 is a mechanism through which tumour cells can evade detection by the immune system. Several therapeutic antibodies targeting PD-L1 or PD-1 have been approved for the treatment of a variety of cancers, however, the discovery and development of small-molecule inhibitors of PD-L1 remains a challenge. Here we report comprehensive sequence-specific backbone resonance assignments ((1)H, (13)C, and (15)N) obtained for the N-terminal IgV-like domain of PD-L1 (D1) and the full two domain extracellular region (D1D2). These NMR assignments will serve as a useful tool in the discovery of small-molecule therapeutics targeting PD-L1 and in the characterisation of functional interactions with other protein partners, such as CD80. |
format | Online Article Text |
id | pubmed-9510113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-95101132022-09-27 Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1 Walker, Kayleigh Waters, Lorna C. Kelly, Geoff Muskett, Frederick W. Carr, Mark D. Biomol NMR Assign Article The co-inhibitory immune checkpoint interaction between programmed cell death-protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) serves to regulate T-cell activation, promoting self-tolerance. Over-expression of PD-L1 is a mechanism through which tumour cells can evade detection by the immune system. Several therapeutic antibodies targeting PD-L1 or PD-1 have been approved for the treatment of a variety of cancers, however, the discovery and development of small-molecule inhibitors of PD-L1 remains a challenge. Here we report comprehensive sequence-specific backbone resonance assignments ((1)H, (13)C, and (15)N) obtained for the N-terminal IgV-like domain of PD-L1 (D1) and the full two domain extracellular region (D1D2). These NMR assignments will serve as a useful tool in the discovery of small-molecule therapeutics targeting PD-L1 and in the characterisation of functional interactions with other protein partners, such as CD80. Springer Netherlands 2022-06-08 2022 /pmc/articles/PMC9510113/ /pubmed/35675028 http://dx.doi.org/10.1007/s12104-022-10092-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Walker, Kayleigh Waters, Lorna C. Kelly, Geoff Muskett, Frederick W. Carr, Mark D. Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1 |
title | Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1 |
title_full | Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1 |
title_fullStr | Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1 |
title_full_unstemmed | Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1 |
title_short | Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1 |
title_sort | sequence-specific (1)h, (13)c and (15)n backbone nmr assignments for the n-terminal igv-like domain (d1) and full extracellular region (d1d2) of pd-l1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510113/ https://www.ncbi.nlm.nih.gov/pubmed/35675028 http://dx.doi.org/10.1007/s12104-022-10092-5 |
work_keys_str_mv | AT walkerkayleigh sequencespecific1h13cand15nbackbonenmrassignmentsforthenterminaligvlikedomaind1andfullextracellularregiond1d2ofpdl1 AT waterslornac sequencespecific1h13cand15nbackbonenmrassignmentsforthenterminaligvlikedomaind1andfullextracellularregiond1d2ofpdl1 AT kellygeoff sequencespecific1h13cand15nbackbonenmrassignmentsforthenterminaligvlikedomaind1andfullextracellularregiond1d2ofpdl1 AT muskettfrederickw sequencespecific1h13cand15nbackbonenmrassignmentsforthenterminaligvlikedomaind1andfullextracellularregiond1d2ofpdl1 AT carrmarkd sequencespecific1h13cand15nbackbonenmrassignmentsforthenterminaligvlikedomaind1andfullextracellularregiond1d2ofpdl1 |